BARBERIO, BRIGIDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.348
AS - Asia 650
EU - Europa 514
SA - Sud America 12
AF - Africa 9
OC - Oceania 3
Totale 3.536
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.336
SG - Singapore 354
IT - Italia 198
CN - Cina 144
FR - Francia 63
HK - Hong Kong 62
FI - Finlandia 59
DE - Germania 53
GB - Regno Unito 40
RU - Federazione Russa 37
VN - Vietnam 35
IN - India 23
NL - Olanda 17
IE - Irlanda 15
BR - Brasile 10
SE - Svezia 9
AT - Austria 8
CA - Canada 7
IR - Iran 5
PH - Filippine 5
EG - Egitto 4
MX - Messico 4
ID - Indonesia 3
JP - Giappone 3
TW - Taiwan 3
AU - Australia 2
CH - Svizzera 2
ES - Italia 2
IL - Israele 2
IQ - Iraq 2
KR - Corea 2
LS - Lesotho 2
NO - Norvegia 2
PK - Pakistan 2
PL - Polonia 2
UA - Ucraina 2
AR - Argentina 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
TM - Turkmenistan 1
TR - Turchia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.536
Salva come PNG Salva come JPEG
Città #
Fairfield 397
Chandler 210
Singapore 200
Santa Clara 144
Ashburn 134
Seattle 134
Woodbridge 134
Cambridge 127
Houston 121
San Diego 91
Wilmington 77
Boardman 72
Hong Kong 60
Medford 59
Princeton 59
Padova 58
Helsinki 55
Roxbury 50
Beijing 47
Ann Arbor 46
Des Moines 40
Dong Ket 30
Milan 18
Pune 17
London 13
Nuremberg 13
Dublin 9
Ogden 8
Falkenstein 7
Los Angeles 7
Verona 6
Washington 6
Curtarolo 5
Menlo Park 5
New York 5
Norwalk 5
Genoa 4
Guangzhou 4
Lappeenranta 4
Manila 4
Mexico City 4
Prescot 4
Shanghai 4
Vienna 4
Villafranca Padovana 4
Cagliari 3
Deiva Marina 3
Hamilton 3
Hanoi 3
Hounslow 3
Kish 3
Liverpool 3
Manchester 3
Peruíbe 3
Rome 3
San Martino Buon Albergo 3
Shenyang 3
São Paulo 3
Zhengzhou 3
Ahmedabad 2
Alexandria 2
Amiens 2
Amsterdam 2
Aversa 2
Baghdad 2
Brendola 2
Calenzano 2
Campi Bisenzio 2
Cernusco sul Naviglio 2
Changsha 2
Chevigny-Saint-Sauveur 2
Chicago 2
Chiswick 2
Daita 2
Groningen 2
Ho Chi Minh City 2
Imola 2
Jacurso 2
Kaohsiung City 2
Kharkiv 2
Lanzhou 2
Las Vegas 2
Lyon 2
Maseru 2
Padang 2
Palermo 2
Ponte Lambro 2
San Jose 2
Stafford 2
Tel Aviv 2
Toronto 2
Venice 2
Vigodarzere 2
Zurich 2
Abidjan 1
Albuquerque 1
Almaty 1
Andover 1
Ashgabat 1
Auckland 1
Totale 2.623
Salva come PNG Salva come JPEG
Nome #
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis 127
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 104
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab 97
Gastrointestinal: An unusual rectal finding in a patient with ulcerative colitis 95
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 94
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success. 92
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach 92
Updates in the field of non-esophageal gastroesophageal reflux disorder 89
A survey on nutritional knowledge in coeliac disease compared to inflammatory bowel diseases patients and healthy subjects 88
Advancements in the use of manometry and impedance testing for esophageal functional disorders 79
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study 79
Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak 78
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 77
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak 73
Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-Tnf: Neutrophil-To-lymphocyte ratio and platelet-To-lymphocyte ratio 73
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 72
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 71
Vonoprazan may provide better results than ppis in helicobacter pylori eradication and beyond – is it time for a change? 70
Perception of the COVID-19 pandemic among patients with inflammatory bowel disease in the time of telemedicine: cross-sectional questionnaire study 70
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis 68
Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters 66
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 64
Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria 63
Medical and gastroenterological education during the COVID-19 outbreak 62
The Lyon Consensus: Does it differ from the previous ones? 62
Vonoprazan fumarate for the treatment of gastric ulcers: A short review on emerging data 59
Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario 57
Prevention Strategies for Esophageal Cancer-An Expert Review 57
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study 54
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 52
The risk of malignancies in celiac disease—A literature review 52
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study 50
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients 49
Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis 49
A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease 49
Eosinophilic esophagitis and biologics 46
Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations 44
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation 44
Hospitalisation for drug infusion did not increase levels of anxiety and the risk of disease relapse in patients with inflammatory bowel disease during covid-19 outbreak 43
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis 41
The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem? 40
Response to Khalaf et al 40
Eosinophilic esophagitis: from pathophysiology to management 39
Reply to letter to the editor: Nlr and plr as novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-Tnf 39
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 39
Eosinophilic Esophagitis and Achalasia: Are We Putting All the Pieces Together? 38
Bariatric Surgery and Esophageal Function: An Eternal Impasse? 37
An "Old" Esophagus 36
Myocarditis and inflammatory bowel diseases: A single-center experience and a systematic literature review 36
MICRO-RNAs TISSUTALI COME BIOMARCATORI DI DIAGNOSI PRECOCE E MONITORAGGIO IN PAZIENTI CON CANCRO DEL COLONRETTO ASSOCIATO A MALATTIA INFIAMMATORIA CRONICA INTESTINALE 34
Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis 34
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 33
Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases 33
Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis 33
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials: Future Treatments for EGIDS: Systematic Review 32
Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms 29
Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis 27
Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis 25
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility 24
Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study 24
Modern diagnosis of early esophageal cancer: From blood biomarkers to advanced endoscopy and artificial intelligence 23
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? 22
Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome 22
Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis 21
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicenter Case Series 21
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis 20
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey 20
Systematic Review: esophageal motility patterns in patients with eosinophilic esophagitis 18
Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER Multicentre Case Series 16
Systematic review with meta-analysis: artificial intelligence in the diagnosis of oesophageal diseases 16
Totale 3.622
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.434
article - articoli 23.321
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.755
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 0 0 0 0 0 0 0 0 10 30 31 4
2020/2021596 29 2 82 2 5 110 110 37 65 39 14 101
2021/2022927 38 56 66 43 115 105 86 44 106 46 42 180
2022/2023514 106 11 24 69 69 59 6 34 57 13 47 19
2023/2024495 41 53 53 41 38 45 45 36 29 14 59 41
2024/20251.003 6 172 99 52 225 52 88 142 167 0 0 0
Totale 3.622